Mur ligase F as a new target for the flavonoids quercitrin, myricetin, and (-)-epicatechin

Martina Hrast Rambaher1, Irena Zdovc2, Nina Kočevar Glavač3

  • 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000, Ljubljana, Slovenia.

Insights

Computer-aided design identified natural compounds as inhibitors of MurF, an enzyme crucial for bacterial peptidoglycan synthesis. (-)-Epicatechin showed promising mixed-type inhibition, highlighting its potential for antibacterial drug discovery.

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Computational Biology

Background:

  • MurC, D, E, and F are essential ATP-dependent ligases in bacterial peptidoglycan synthesis.
  • These enzymes are highly conserved and exclusively found in bacteria, making them attractive targets for novel antibacterial agents.

Purpose of the Study:

  • To identify potential inhibitors of MurF using a computer-aided molecular design approach.
  • To evaluate the inhibitory activity of selected flavonoids and related compounds against MurC-F enzymes.
  • To elucidate the binding modes and key structural features of active compounds.

Main Methods:

  • Computer-aided molecular design for inhibitor identification.
  • Biochemical inhibition assays screening 24 flavonoids against MurC-F.
  • Enzyme kinetics to determine inhibition type and IC50 values.
  • In silico analysis using Sitemap and Glide docking for binding site prediction.

Main Results:

  • Quercitrin, myricetin, and (-)-epicatechin were identified as MurF inhibitors with IC50 values of 143 µM, 139 µM, and 92 µM, respectively.
  • (-)-Epicatechin exhibited mixed-type inhibition against ATP and uncompetitive inhibition against D-Ala-D-Ala dipeptide and UM3DAP substrates.
  • In silico analysis revealed two potential binding sites for (-)-epicatechin, with structural features like substitution patterns and hydroxyl groups being critical for activity.

Conclusions:

  • Computational approaches are effective in discovering inhibitors of essential bacterial enzymes like MurF.
  • Flavonoids, particularly (-)-epicatechin, show potential as starting points for developing new antibacterial drugs targeting peptidoglycan synthesis.
  • Understanding structure-activity relationships is key for optimizing inhibitor design.